Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Harmony Biosciences Holdings Inc’s stock clocked out at $34.95, down -1.30% from its previous closing price of $35.41. In other words, the price has decreased by -$1.30 from its previous closing price. On the day, 0.73 million shares were traded. HRMY stock price reached its highest trading level at $35.44 during the session, while it also had its lowest trading level at $34.63.
Ratios:
To gain a deeper understanding of HRMY’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.33. For the most recent quarter (mrq), Quick Ratio is recorded 3.09 and its Current Ratio is at 3.13. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.32.
On September 10, 2024, UBS started tracking the stock assigning a Buy rating and target price of $56.
On June 21, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $48.Citigroup initiated its Buy rating on June 21, 2024, with a $48 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 03 ’24 when JEFFREY G DIERKS bought 14,961 shares for $35.57 per share.
Dierks Jeffrey sold 400 shares of HRMY for $16,077 on Oct 01 ’24. The CHIEF COMMERCIAL OFFICER now owns 0 shares after completing the transaction at $40.19 per share. On Oct 01 ’24, another insider, JEFFREY G DIERKS, who serves as the Officer of the company, bought 21,796 shares for $40.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HRMY now has a Market Capitalization of 1986372864 and an Enterprise Value of 1854670336. As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.90, and their Forward P/E ratio for the next fiscal year is 10.38. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.03 while its Price-to-Book (P/B) ratio in mrq is 3.69. Its current Enterprise Value per Revenue stands at 2.827 whereas that against EBITDA is 9.159.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $40.60, while it has fallen to a 52-week low of $18.79. The 50-Day Moving Average of the stock is -3.96%, while the 200-Day Moving Average is calculated to be 6.98%.
Shares Statistics:
It appears that HRMY traded 432.10K shares on average per day over the past three months and 606870 shares per day over the past ten days. A total of 56.77M shares are outstanding, with a floating share count of 30.67M. Insiders hold about 46.03% of the company’s shares, while institutions hold 65.49% stake in the company. Shares short for HRMY as of 1727654400 were 8538118 with a Short Ratio of 19.76, compared to 1724976000 on 8755100. Therefore, it implies a Short% of Shares Outstanding of 8538118 and a Short% of Float of 67.07.
